David M. Spencer, Chief Scientific Officer at BELLICUM PHARMACEUTICALS, INC (BLCM), sold 5,000 shares at $20.00 ($100K) on 2016-12-05, disclosed to the SEC on 2016-12-05.
Open-market sale of $100k BLCM by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| BLCM | SELL | 2017-07-12 | $231K | — | Filing → |
| BLCM | SELL | 2016-12-05 | $139K | — | Filing → |
| BLCM | SELL | 2016-09-23 | $453K | — | Filing → |